Last edition
News about "Specialised Therapeutics"
Australia Approves First-in-Class Niktimvo for Chronic GVHD Treatment
Niktimvo approval marks a major breakthrough in treating chronic GVHD, introducing a first-in-class targeted therapy for patients with limited treatment options and high unmet medical need.
Specialised Therapeutics | 05/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members